Leszek B Kiliman
Examiner (ID: 1930, Phone: (571)272-1509 , Office: P/1788 )
Most Active Art Unit | 1773 |
Art Unit(s) | 1788, 1787, 1509, 1316, 1773, 1794 |
Total Applications | 2689 |
Issued Applications | 2219 |
Pending Applications | 93 |
Abandoned Applications | 377 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6055800
[patent_doc_number] => 20110112160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'TABLET COMPRISING EPROSARTAN MESYLATE'
[patent_app_type] => utility
[patent_app_number] => 12/937135
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11255
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112160.pdf
[firstpage_image] =>[orig_patent_app_number] => 12937135
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937135 | TABLET COMPRISING EPROSARTAN MESYLATE | Apr 7, 2009 | Abandoned |
Array
(
[id] => 7742119
[patent_doc_number] => 20120020901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'ORAL CARE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/262353
[patent_app_country] => US
[patent_app_date] => 2009-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3571
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20120020901.pdf
[firstpage_image] =>[orig_patent_app_number] => 13262353
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262353 | ORAL CARE COMPOSITIONS | Apr 1, 2009 | Abandoned |
Array
(
[id] => 6551433
[patent_doc_number] => 20100233231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 12/401228
[patent_app_country] => US
[patent_app_date] => 2009-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12060
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233231.pdf
[firstpage_image] =>[orig_patent_app_number] => 12401228
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/401228 | USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION | Mar 9, 2009 | Abandoned |
Array
(
[id] => 6102656
[patent_doc_number] => 20110166149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'PTERIDINE DERIVATIVES FOR TREATING RESPIRATORY DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/866665
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5715
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166149.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866665
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866665 | PTERIDINE DERIVATIVES FOR TREATING RESPIRATORY DISEASE | Feb 5, 2009 | Abandoned |
Array
(
[id] => 5986821
[patent_doc_number] => 20110098267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS'
[patent_app_type] => utility
[patent_app_number] => 12/866735
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 41916
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098267.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866735
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866735 | TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS | Feb 5, 2009 | Abandoned |
Array
(
[id] => 6214391
[patent_doc_number] => 20110136877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => '2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/811823
[patent_app_country] => US
[patent_app_date] => 2009-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14434
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136877.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811823
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811823 | 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS | Jan 5, 2009 | Abandoned |
Array
(
[id] => 6014978
[patent_doc_number] => 20110223226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'SHELF STABLE CAPSULES'
[patent_app_type] => utility
[patent_app_number] => 13/128243
[patent_app_country] => US
[patent_app_date] => 2008-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4589
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20110223226.pdf
[firstpage_image] =>[orig_patent_app_number] => 13128243
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/128243 | Shelf stable capsules | Nov 9, 2008 | Issued |
Array
(
[id] => 5944829
[patent_doc_number] => 20110105449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'DRY POWDER FORMULATIONS COMPRISING ASCORBIC ACID DERIVATES'
[patent_app_type] => utility
[patent_app_number] => 12/740921
[patent_app_country] => US
[patent_app_date] => 2008-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6378
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105449.pdf
[firstpage_image] =>[orig_patent_app_number] => 12740921
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740921 | DRY POWDER FORMULATIONS COMPRISING ASCORBIC ACID DERIVATES | Nov 5, 2008 | Abandoned |
Array
(
[id] => 10018491
[patent_doc_number] => 09060960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Treatment of dissection, aneurysm, and atherosclerosis using granzyme B inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/681293
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17339
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681293
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681293 | Treatment of dissection, aneurysm, and atherosclerosis using granzyme B inhibitors | Sep 30, 2008 | Issued |
Array
(
[id] => 10031370
[patent_doc_number] => 09072670
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Matrix-type pharmaceutical solid preparation'
[patent_app_type] => utility
[patent_app_number] => 12/738543
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 19453
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12738543
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738543 | Matrix-type pharmaceutical solid preparation | Sep 25, 2008 | Issued |
Array
(
[id] => 10082489
[patent_doc_number] => 09119819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-01
[patent_title] => 'Oral liquid compositions of rhein or diacerein'
[patent_app_type] => utility
[patent_app_number] => 12/989966
[patent_app_country] => US
[patent_app_date] => 2008-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3415
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12989966
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989966 | Oral liquid compositions of rhein or diacerein | Sep 22, 2008 | Issued |
Array
(
[id] => 8896247
[patent_doc_number] => 08475768
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (MRI)'
[patent_app_type] => utility
[patent_app_number] => 12/672113
[patent_app_country] => US
[patent_app_date] => 2008-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16736
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12672113
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/672113 | Paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (MRI) | Aug 11, 2008 | Issued |
Array
(
[id] => 6283965
[patent_doc_number] => 20100236550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'DRY-POWDER MEDICAMENT'
[patent_app_type] => utility
[patent_app_number] => 12/669523
[patent_app_country] => US
[patent_app_date] => 2008-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5500
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20100236550.pdf
[firstpage_image] =>[orig_patent_app_number] => 12669523
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669523 | DRY-POWDER MEDICAMENT | Jul 17, 2008 | Abandoned |
Array
(
[id] => 6603162
[patent_doc_number] => 20100323025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'TIMED-RELEASE PHARMACEUTICAL PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 12/866634
[patent_app_country] => US
[patent_app_date] => 2008-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10213
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0323/20100323025.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866634
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866634 | TIMED-RELEASE PHARMACEUTICAL PREPARATION | Jun 29, 2008 | Abandoned |
Array
(
[id] => 6163532
[patent_doc_number] => 20110160302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'DEVICE AND METHODS FOR TREATMENT AND PREVENTION OF TENDON INJURIES'
[patent_app_type] => utility
[patent_app_number] => 12/452195
[patent_app_country] => US
[patent_app_date] => 2008-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5046
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160302.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452195
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452195 | DEVICE AND METHODS FOR TREATMENT AND PREVENTION OF TENDON INJURIES | Jun 15, 2008 | Abandoned |
Array
(
[id] => 9983613
[patent_doc_number] => 09029322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-12
[patent_title] => 'Compounds for enhancing p21 expression and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/663091
[patent_app_country] => US
[patent_app_date] => 2008-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 5
[patent_no_of_words] => 6386
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12663091
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/663091 | Compounds for enhancing p21 expression and methods of use thereof | Jun 4, 2008 | Issued |
Array
(
[id] => 11217663
[patent_doc_number] => 09445982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Polymer-based pigment-bearing ink'
[patent_app_type] => utility
[patent_app_number] => 12/124194
[patent_app_country] => US
[patent_app_date] => 2008-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4294
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12124194
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/124194 | Polymer-based pigment-bearing ink | May 20, 2008 | Issued |
Array
(
[id] => 4726646
[patent_doc_number] => 20080206187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'METHOD FOR TREATING A NEOPLASTIC DISORDER'
[patent_app_type] => utility
[patent_app_number] => 11/947375
[patent_app_country] => US
[patent_app_date] => 2007-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12128
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206187.pdf
[firstpage_image] =>[orig_patent_app_number] => 11947375
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/947375 | Method for treating a neoplastic disorder | Nov 28, 2007 | Issued |
Array
(
[id] => 5278046
[patent_doc_number] => 20090130178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'FORMULATION FOR DECREASING TOBACCO, ALCOHOL, DRUG OR FOOD CONSUMPTION'
[patent_app_type] => utility
[patent_app_number] => 11/942414
[patent_app_country] => US
[patent_app_date] => 2007-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4091
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130178.pdf
[firstpage_image] =>[orig_patent_app_number] => 11942414
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/942414 | Formulation for decreasing tobacco, alcohol, drug or food consumption | Nov 18, 2007 | Issued |
Array
(
[id] => 6629525
[patent_doc_number] => 20100311655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'INTRANASAL CARBETOCIN FORMULATIONS AND METHODS FOR THE TREATMENT OF AUTISM'
[patent_app_type] => utility
[patent_app_number] => 12/599267
[patent_app_country] => US
[patent_app_date] => 2007-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32793
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311655.pdf
[firstpage_image] =>[orig_patent_app_number] => 12599267
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/599267 | INTRANASAL CARBETOCIN FORMULATIONS AND METHODS FOR THE TREATMENT OF AUTISM | Sep 27, 2007 | Abandoned |